Isomorphic Labs alternatives

Generate Biomedicines uses a generative AI platform to design novel protein therapeutics from scratch, focusing on a diverse range of therapeutic modalities.

Xaira Therapeutics integrates cutting-edge AI research, including technologies like RFdiffusion, with therapeutic development to design novel proteins and antibodies for complex biological challenges.

Latent Labs is building generative AI models for de novo protein design, with a focus on creating entirely new therapeutic molecules like antibodies and enzymes to make biology more programmable.

DenovAI offers an AI-driven platform, AlphaDesign, capable of creating new, functional synthetic proteins entirely de novo without requiring training on evolutionary data or using known protein templates.

ProteinQure specializes in the AI-driven design of novel exotic peptides with broad therapeutic applications, leveraging its ProteinStudio™ computational platform for de novo peptide design and tissue-specific delivery.